354 related articles for article (PubMed ID: 27507261)
1. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.
Li W; Shen LJ; Chen T; Sun XQ; Zhang Y; Wu M; Shu WH; Chen C; Pan CC; Xia YF; Wu PH
Chin J Cancer; 2016 Aug; 35(1):75. PubMed ID: 27507261
[TBL] [Abstract][Full Text] [Related]
2. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
3. [Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].
Wang CT; Cao KJ; Li Y; Xie GF; Huang PY
Ai Zheng; 2007 Feb; 26(2):212-5. PubMed ID: 17298756
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma].
Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217
[TBL] [Abstract][Full Text] [Related]
5. The results and prognosis of different treatment modalities for solitary metastatic lung tumor from nasopharyngeal carcinoma: a retrospective study of 105 cases.
Ma J; Wen ZS; Lin P; Wang X; Xie FY
Chin J Cancer; 2010 Sep; 29(9):787-95. PubMed ID: 20800020
[TBL] [Abstract][Full Text] [Related]
6. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of responses and prognostic factors in different chemotherapy regimens for metastatic nasopharyngeal carcinoma: a report of 171 cases].
Zhou J; Zhang WM; Chen H; Xie B; Zheng JH; Xu ZY; Lin JR
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):867-72. PubMed ID: 20137355
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: findings from a randomised trial.
Huang PY; Wang CT; Cao KJ; Guo X; Guo L; Mo HY; Wen BX; Wu YS; Mai HQ; Hong MH
Eur J Cancer; 2013 May; 49(8):1923-31. PubMed ID: 23434149
[TBL] [Abstract][Full Text] [Related]
9. A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasis.
Zeng Z; Shen L; Wang Y; Shi F; Chen C; Wu M; Bai Y; Pan C; Xia Y; Wu P; Li W
Medicine (Baltimore); 2016 Jul; 95(27):e4026. PubMed ID: 27399084
[TBL] [Abstract][Full Text] [Related]
10. Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy.
Lin GN; Peng JW; Liu DY; Xiao JJ; Chen YQ; Chen XQ
Tumour Biol; 2014 Nov; 35(11):10849-54. PubMed ID: 25081376
[TBL] [Abstract][Full Text] [Related]
11. Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis.
Chen MY; Jiang R; Guo L; Zou X; Liu Q; Sun R; Qiu F; Xia ZJ; Huang HQ; Zhang L; Hong MH; Mai HQ; Qian CN
Chin J Cancer; 2013 Nov; 32(11):604-13. PubMed ID: 24206918
[TBL] [Abstract][Full Text] [Related]
12. Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapy.
Gennari A; Nanni O; Puntoni M; DeCensi A; Scarpi E; Conte P; Antonucci G; Amadori D; Bruzzi P
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1862-7. PubMed ID: 23945199
[TBL] [Abstract][Full Text] [Related]
13. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P; Lee CC; Chen LF
Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
[TBL] [Abstract][Full Text] [Related]
14. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
15. Obesity is an independent prognostic variable in colon cancer survivors.
Sinicrope FA; Foster NR; Sargent DJ; O'Connell MJ; Rankin C
Clin Cancer Res; 2010 Mar; 16(6):1884-93. PubMed ID: 20215553
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment Body Mass Index (BMI) as an Independent Prognostic Factor in Nasopharyngeal Carcinoma Survival: A Systematic Review and Meta-Analysis.
Jin X; Hu R; Guo H; Ding C; Pi G; Tian M
Nutr Cancer; 2022; 74(10):3457-3467. PubMed ID: 35658769
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide and doxorubicin combination chemotherapy for recurrent nasopharyngeal carcinoma patients.
Dede DS; Aksoy S; Cengiz M; Gullu I; Altundag K
Asian Pac J Cancer Prev; 2012; 13(5):2225-8. PubMed ID: 22901198
[TBL] [Abstract][Full Text] [Related]
18. Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF-targeted therapies.
Patel GS; Ullah S; Beeke C; Hakendorf P; Padbury R; Price TJ; Karapetis CS
Cancer Med; 2015 Oct; 4(10):1461-71. PubMed ID: 26211512
[TBL] [Abstract][Full Text] [Related]
19. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.
Sun P; Chen C; Xia Y; Bi X; Liu P; Zhang F; Yang H; An X; Jiang W; Wang F
Dis Markers; 2017; 2017():6570808. PubMed ID: 28676731
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
